Literature DB >> 6418891

Importance of unbound phenytoin serum levels in head trauma patients.

L A Bauer, W A Edwards, E P Dellinger, V A Raisys, C Brennan.   

Abstract

Total (bound + unbound) and unbound phenytoin serum concentrations were measured in ten male comatose head trauma patients and ten male epileptic patients. Serum biochemistry and complete blood cell counts were normal for both groups, except albumin concentrations were below normal in the head trauma patients for nutritional reasons. Total phenytoin concentrations were 6.8 +/- 1.8 mcg/ml for the head trauma patients and 14.5 +/- 3.0 mcg/ml for the epileptic patients (p less than 0.0002) even though phenytoin doses were similar. However, unbound phenytoin concentrations were within the therapeutic range of 1 to 2 mcg/ml for both groups and were not significantly different. Had only the total concentrations been measured, phenytoin doses might have been increased inappropriately in the head trauma patients. The reason head trauma patients had therapeutic unbound concentrations despite lower total concentrations was that the unbound per cent of phenytoin was higher in these patients (21 +/- 3.2%) than in the epileptic patients (10 +/- 1.3%, p less than 0.0002).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418891     DOI: 10.1097/00005373-198312000-00007

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  6 in total

1.  Effect of time, injury, age and ethanol on interpatient variability in valproic acid pharmacokinetics after traumatic brain injury.

Authors:  Gail D Anderson; Nancy R Temkin; Asaad B Awan; H Richard Winn; Richard H Winn
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 2.  Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients.

Authors:  B K Wagner; D A O'Hara
Journal:  Clin Pharmacokinet       Date:  1997-12       Impact factor: 6.447

Review 3.  Pharmacokinetic alterations after severe head injury. Clinical relevance.

Authors:  B A Boucher; S D Hanes
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

4.  Decreased plasma protein binding of valproate in patients with acute head trauma.

Authors:  G D Anderson; B E Gidal; R J Hendryx; A B Awan; N R Temkin; A J Wilensky; H R Winn
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

5.  Correlation between measured and calculated free phenytoin serum concentration in neurointensive care patients with hypoalbuminemia.

Authors:  Seyyede-Sareh Javadi; Reza Mahjub; Abbas Taher; Younes Mohammadi; Maryam Mehrpooya
Journal:  Clin Pharmacol       Date:  2018-12-13

6.  Pharmacokinetic Behavior of Phenytoin in Head Trauma and Cerebrovascular Accident Patients in an Iranian Population.

Authors:  Shahnaz Alimardani; Sima Sadrai; Hamidreza Taghvaye Masoumi; Pooneh Salari; Atabak Najafi; Behzad Eftekhar; Mojtaba Mojtahedzadeh
Journal:  J Res Pharm Pract       Date:  2017 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.